Sentences with phrase «new cardiovascular research»
Dr. John Ross Jr., chief of the National Heart Institute's section on cardiovascular diagnosis, is recruited to head the new cardiovascular research and training program.
https://health.ucsd.edu/ Not exact matches
If those are your reasons for not improving your cardiovascular fitness, check this out: New research from McMaster University shows that ten minutes of stair climbing — ten minutes that includes warming up, cooling down, and recovering between sets — measurably improved cardiovascular fitness.
Salt may raise blood pressure by making it harder for the cardiovascular system to juggle the regulation of blood pressure and body temperature, according to new research.
High sodium intake, especially when combined with a low potassium intake, is associated with an increased risk of cardiovascular disease and mortality, according to new research.
New research from the University of Copenhagen and Herlev and Gentofte Hospital shows that high vitamin C concentrations in the blood from the intake of fruit and vegetables are associated with a reduced risk of cardiovascular disease and early death.
According to researchers, their future research will analyze the cost - effectiveness of a new strategy of incorporating these non-invasive imaging tools into future prevention and diagnostic protocols for cardiovascular disease and to better define their use.
New research reveals that depressive symptoms, stress, anxiety, and anger and lack of social support in patients with rheumatoid arthritis (RA) were linked to atherosclerosis — a build - up of fatty deposits in the arteries that contributes to cardiovascular disease.
A new narrative review authored by Carl Streed Jr., MD, at Brigham and Women's Hospital, published in the Annals of Internal Medicine, discusses how more research is needed to better understand cardiovascular disease (CVD) and CVD risk factors in transgender patients receiving long term cross-sex hormone therapy.
Homeless people with mental disease have a greater than double risk of developing serious or fatal cardiovascular disease over 30 years than people of the same age and gender with no risk factors for the disease, new research has found.
Germany's Max Delbrück Center for Molecular Medicine (MDC) Berlin Buch and the Fu Wai Hospital of the Chinese Academy of Medical Sciences (CAMS) are building a new gene research laboratory in Beijing, the aim being to identify genes that play a key role in the pathogenesis of cardiovascular diseases.
If further research shows that we can control the mechanism that triggers natural cardiovascular protection, it may be possible to develop new treatment protocols for coronary artery disease.»
This new research suggests that smokers may be more susceptible to the illnesses associated with poor sleep along with the more commonly recognised health problems associated with smoking such as cancer and cardiovascular disease.
«Our findings demonstrate that people naturally assign different weights to the pluses and minuses of interventions to improve cardiovascular health,» said Erica Spatz, M.D., M.H.S., the study lead author and an assistant professor of cardiovascular medicine in the Center for Outcomes Research and Evaluation at Yale School of Medicine in New Haven, CT. «I believe we need to tap into this framework when we are talking with patients about options to manage their blood pressure.
«Poverty and the many stresses that come with social disadvantage have long been linked to cardiovascular disease, but how we live, work, and play has a great impact on heart health for people from a broad range of economic and cultural backgrounds,» explains David Siscovick, MD, MPH, Senior Vice President for Research at The New York Academy of Medicine and Chair of the American Heart Association's (AHA) Council on Epidemiology and Prevention.
More extensive research and new interventions are needed, he adds, if we are to reach the AHA's goal of increasing the proportion of the population in ideal cardiovascular health by 2020.
Brominated fire retardants, used in many consumer products and known to cause hormonal irregularities, overstimulates an adrenal gland hormone in a way that may lead to the development of cardiovascular disease, new research in human cells finds.
But some recent developments indicate that things are changing, and with the incorporation last year of the first research groups into the new Centro Nacional de Investigaciones Cardiovasculares (national centre for cardiovascular research) Carlos III (CNIC), the move to transform Spanish biomedical research entered a new phase.
When CNIC finally consolidates its activities in a new building, which begins construction this month in Madrid, it will mark the end of the beginning for an ambitious long - term project to establish a world - class centre for cardiovascular research in Spain.
«We've known for a long time that exercise protects against metabolic and cardiovascular disease,» says Robert Gerszten, director of Translational Research in the Cardiology Division at Massachusetts General Hospital, and co-author of the new study.
These will all form part of a co-ordinated effort to create a meeting point for all those with an interest in cardiovascular research, bringing scientists, clinicians, and the private sector together to accelerate the transfer of new developments from the bench to the clinic.
Traffic - related air pollution may increase cardiovascular disease risk by lowering levels of high - density lipoprotein (HDL), commonly known as «good» cholesterol, according to new research in the American Heart Association's journal Arteriosclerosis, Thrombosis, and Vascular Biology.
LA JOLLA, CA — New research from scientists at the La Jolla Institute for Allergy and Immunology shows how a diet high in fat and cholesterol depletes the ranks of artery - protecting immune cells, turning them into promoters of inflammation, which exacerbate atherosclerotic plaque buildup that occurs in cardiovascular disease.
In a new study, a research team has tested various cardiovascular measures in six astronauts on long - term missions aboard the International Space Station.
Prior to that, Graziano spent five years working in academic research at New York University's School of Medicine, studying oncology and cardiovascular diseases.
Career Goals: Peipei is passionately building up her career as professional research investigator to continue unraveling the mystery of aberrant myelopoiesis with the goal of developing new generation of therapeutic method for cancer & cardiovascular disease.
These highly competitive funds enable UCSF scientists to pursue research aimed at advancing understanding of human health and disease, and developing new therapies for neurological diseases, cancer, diabetes, cardiovascular disease, and a host of other conditions.
SAN FRANCISCO, CA — A new biopharmaceutical company, Tenaya Therapeutics Inc., will build on discoveries in cardiovascular disease research made at the Gladstone Institutes, concentrating on regenerative medicine and drug discovery for heart failure.
LA JOLLA, CA — New research from scientists at the La Jolla Institute For Allergy and Immunology shows how a diet high in fat and cholesterol depletes the ranks of artery - protecting immune cells, turning them into promoters of inflammation, which exacerbate atherosclerotic plaque buildup that occurs in cardiovascular disease.
In a new study, a research team, which includes Western University kinesiology professor Kevin Shoemaker, has tested various cardiovascular measures in six astronauts on long - term missions aboard the International Space Station.
An alternative approach pioneered by Deepak Srivastava, MD, director of cardiovascular and stem cell research at Gladstone, used genes to convert scar - forming cells in the heart of animals into new muscle that improved the function of the heart.
Susan Amara, USA - «Regulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transporters
Vasculata ™ 2018 will be an intense 3 1/2 day course introducing the basics of cardiovascular biology and cardiovascular disease with an emphasis on new approaches to treating the most common causes of human disease in our society, based on cutting - edge research in the field.
According to new research out of the University of Surrey, healthy people who eat a high - sugar diet (in this case, 650 calories» worth of sugar per day) have an altered fat metabolism that puts them at higher risk for cardiovascular disease.
Newer research confirms many of the old findings on these chemicals — endocrine disruption (in adults and babies), thyroid disruption, and increase risk of cardiovascular disease, diabetes and liver enzyme abnormalities.3 And recently, the Yale School of Medicine found that BPA «causes the loss of connections of brain cells,» which increases the risk for memory problems and even depression.4
New Info: The research proves fish oil lowers cardiovascular...
Living with eczema does not mean you're at a higher risk for developing cardiovascular diseases like diabetes or stroke, according to new research.
Now, newer research from the American Journal of Clinical Nutrition has revealed that the consumption of chocolate, or its active constituents (cocoa, flavan -3-ols), reduces a broad range of risk factors for cardiovascular disease, some of which include insulin resistance.
Now, new research points to the possibility that beneficial gut bacteria may help combat cardiovascular disease as well.
In fact, new research is showing that probiotics have the potential to even lower high blood pressure, leading to a more healthier cardiovascular response.
The faculty research tends to focus on such public health issues as TB, obesity, and cardiovascular disease, though that focus is expanding into new research areas such as genetics and how the field impacts communicable disease.
Recent research out of New York University's Lagone Medical Center found that married people had a 5 % lower chance of cardiovascular disease compared to single people.